What are the next steps for a 10-year-old patient with low hematocrit (low red blood cell count), normal hemoglobin, normal white blood cell (WBC) count, elevated absolute eosinophil count and elevated absolute basophil count, borderline mean platelet volume (MPV), and normal platelet count?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Workup for Eosinophilia and Basophilia in a 10-Year-Old

Your immediate next step is to obtain a peripheral blood smear to evaluate white blood cell morphology and maturity, followed by targeted testing for parasitic infections, allergic conditions, and consideration of clonal eosinophilia with JAK2 mutation testing if no secondary cause is identified. 1, 2

Initial Laboratory Evaluation

Peripheral Blood Smear (Mandatory First Step)

  • Examine for white blood cell maturity, uniformity, and presence of toxic granulations to distinguish reactive from clonal processes 2
  • Assess red blood cell morphology to evaluate the discrepancy between low hematocrit and normal hemoglobin (may indicate technical artifact or specific red cell abnormalities) 3
  • Evaluate platelet morphology given the borderline mean platelet volume 4

Complete Blood Count Verification

  • Repeat the CBC to confirm the eosinophilia and basophilia are sustained findings, as transient elevations can occur with viral infections or stress 2
  • Document absolute eosinophil count; sustained elevation ≥1500 cells/μL for at least 6 months defines hypereosinophilic syndrome if organ damage is present 1
  • Verify the hematocrit-hemoglobin discrepancy is reproducible 5

Systematic Evaluation for Secondary Eosinophilia

Parasitic Infections (Most Common Cause in Children)

  • Obtain stool ova and parasites (3 samples) for tissue-invasive parasites 1
  • Consider serologic testing for strongyloides, toxocara, and other endemic parasites based on exposure history 1
  • Eosinophilia with parasitic infections specifically occurs with tissue-invasive phases 3

Allergic and Inflammatory Conditions

  • Evaluate for asthma, atopic dermatitis, drug reactions, and allergic rhinitis 1
  • Consider inflammatory bowel disease if gastrointestinal symptoms are present 2

Medication Review

  • Identify any medications that could cause eosinophilia (antibiotics, anticonvulsants, NSAIDs) 2

Evaluation for Primary (Clonal) Eosinophilia

When to Suspect Clonal Disease

  • If no secondary cause is identified after thorough evaluation 1
  • Presence of concurrent basophilia increases suspicion for myeloproliferative disorder 1
  • Any symptoms suggesting hematologic malignancy: fever, weight loss, bruising, fatigue, or splenomegaly 2

Molecular and Cytogenetic Testing

  • JAK2 V617F mutation testing should be performed if clonal eosinophilia is suspected, as this identifies imatinib-sensitive molecular targets 1
  • Test for PDGFR-alpha and PDGFR-beta gene rearrangements, which predict response to imatinib therapy 1
  • These tests are critical because they directly impact treatment decisions 1

Addressing the Hematocrit-Hemoglobin Discrepancy

Technical and Physiologic Considerations

  • Low hematocrit with normal hemoglobin is unusual and may represent:
    • Laboratory artifact or specimen handling issue (most common) 5
    • Mild dehydration affecting hematocrit measurement 6
    • Early bone marrow process affecting red cell production 5

Additional Testing if Discrepancy Persists

  • Reticulocyte count to assess bone marrow response 3, 5
  • Iron studies (ferritin, transferrin saturation, serum iron) to exclude iron deficiency 3, 5
  • Mean corpuscular volume (MCV) to characterize any anemia 3

Borderline Mean Platelet Volume Interpretation

Clinical Significance

  • Borderline MPV with normal platelet count is generally not concerning in isolation 4
  • Low MPV would suggest bone marrow hypoplasia, sepsis, or myelosuppressive drugs, but your patient has normal platelet count 4, 7
  • High MPV would suggest hyperdestructive processes or myeloproliferative disorders 4, 7

Critical Red Flags Requiring Urgent Hematology Referral

  • Presence of immature white blood cells (blasts) on peripheral smear 2
  • Progressive cytopenias on repeat CBC 5
  • Splenomegaly or lymphadenopathy on examination 2
  • Constitutional symptoms (fever, weight loss, night sweats) 2
  • Absolute eosinophil count >1500 cells/μL with any organ symptoms (cardiac, pulmonary, neurologic, or skin involvement) 1

Common Pitfalls to Avoid

  • Do not dismiss eosinophilia as "reactive" without systematic evaluation for parasites and allergic conditions 1
  • Do not delay JAK2 testing if no secondary cause is found, as clonal eosinophilia requires different management 1
  • Do not ignore the concurrent basophilia, as dual elevation increases concern for myeloproliferative process 1
  • Do not assume the hematocrit-hemoglobin discrepancy is artifact without verification 5

Timeline for Evaluation

  • Peripheral smear and repeat CBC: within 1 week 2
  • Stool studies and basic secondary cause evaluation: within 2 weeks 1
  • JAK2 and molecular testing if indicated: within 2-4 weeks 1
  • Hematology referral if diagnosis uncertain or clonal disease suspected: within 4 weeks 2

References

Research

Evaluation of Patients with Leukocytosis.

American family physician, 2015

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic and Management of Decreased Mean Platelet Volume with Decreased Hematocrit

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Blood Tests for Monitoring Polycythemia Vera

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Platelet size in health and hematologic disease.

American journal of clinical pathology, 1982

Related Questions

What are the concerns with a low Mean Platelet Volume (MPV) in patients with underlying hematological conditions or those taking certain medications?
What is the normal range for Mean Platelet Volume (MPV) on a Complete Blood Count (CBC) and what conditions can cause it to be elevated or decreased?
What is the diagnosis and treatment for a patient with leukocytosis (high White Blood Cell (WBC) count), thrombocytosis (high platelet count), anemia (low hemoglobin (Hb)), normal Mean Corpuscular Volume (MCV), and normal Mean Corpuscular Hemoglobin (MCH)?
What is the best course of action for an 11-year-old male with leukocytosis (elevated WBC count of 10.7), lymphocytes at 4.5, and eosinophils at 0.5?
What is the best approach for a 13-year-old boy with leukocytosis and fatigue, and no past medical history?
What is the drug of choice for a patient with Hospital-Acquired Pneumonia (HAP)?
What is the management and treatment plan for a patient with a fusiform dilatation of the abdominal aorta measuring 39mm in AP diameter?
Is imaging necessary for a patient with iliotibial (IT) band syndrome in the initial evaluation?
What is the recommended course of action for a general patient population based on studies regarding a specific disease or condition, such as diabetes or cardiovascular disease?
What is the recommended dose of Laryica for an adult patient with End-Stage Renal Disease (ESRD) on Hemodialysis (HD)?
What is the proper dosage and administration schedule for Duphaston (Dydrogesterone)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.